111 Capital’s Sabra Healthcare REIT SBRA Stock Holding History

111 Capital’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,106	Closed	-$282K	–	510
2025 Q3	$282K	Buy	+15,106	New	+$282K	0.05%	331

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

111 Capital's SBRA Position: Q4 2025 in Review

111 Capital sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 15,106 shares — an estimated $282K sold.

111 Capital first reported a position in SBRA in Q3 2025 and held it in 1 quarter. The position peaked at $282K in Q3 2025. 441 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

111 Capital reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
111 Capital sold 15,106 Sabra Healthcare REIT shares in Q4 2025, an estimated $282K.
111 Capital first reported a position in Sabra Healthcare REIT in Q3 2025 and held it in 1 quarter.
111 Capital's Sabra Healthcare REIT position peaked at $282K in Q3 2025.
441 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on 111 Capital's 13F filing for Q4 2025, filed 11 Feb 2026.